23. Nanoparticles for Combined Cancer Imaging and Therapy

  1. Xiaoyuan Chen2,3
  1. Vaishali Bagalkot,
  2. Mi Kyung YU and
  3. Sangyong Jon

Published Online: 25 MAY 2011

DOI: 10.1002/9780470767047.ch23

Nanoplatform-Based Molecular Imaging

Nanoplatform-Based Molecular Imaging

How to Cite

Bagalkot, V., Kyung YU, M. and Jon, S. (2011) Nanoparticles for Combined Cancer Imaging and Therapy, in Nanoplatform-Based Molecular Imaging (ed X. Chen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470767047.ch23

Editor Information

  1. 2

    Molecular Imaging Program at Stanford and Bio-X Program, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA

  2. 3

    Laboratory for Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA

Author Information

  1. School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, South Korea

Publication History

  1. Published Online: 25 MAY 2011
  2. Published Print: 28 MAR 2011

ISBN Information

Print ISBN: 9780470521151

Online ISBN: 9780470767047



  • nanoparticles, for combined cancer imaging and therapy;
  • cancer chemotherapy, benefits from nanosized drug carriers - targeting tumor sites, enhancing drug efficacy, reducing nonspecific toxicities and raising the therapeutic index;
  • multifunctional polymeric micelles - as cancer-targeted, MRI-ultrasensitive drug delivery systems


This chapter contains sections titled:

  • Introduction

  • Design Principles of Nanoparticles for In Vivo Imaging and Therapy

  • Multifunctional Nanoparticles for Combined Cancer Imaging and Therapy: Various Examples

  • Prospects and Challenges for Translation into Clinics

  • References